Affiliation:
1. College of Pharmacy, University of Illinois, Chicago, IL 61820, USA
2. Zamara Mariam, School of Interdisciplinary Engineering & Sciences (SINES), National University of Sciences & Technology (NUST), Islamabad 24090, Pakistan
Abstract
In modern drug discovery, the combination of chemoinformatics and quantitative structure–activity relationship (QSAR) modeling has emerged as a formidable alliance, enabling researchers to harness the vast potential of machine learning (ML) techniques for predictive molecular design and analysis. This review delves into the fundamental aspects of chemoinformatics, elucidating the intricate nature of chemical data and the crucial role of molecular descriptors in unveiling the underlying molecular properties. Molecular descriptors, including 2D fingerprints and topological indices, in conjunction with the structure–activity relationships (SARs), are pivotal in unlocking the pathway to small-molecule drug discovery. Technical intricacies of developing robust ML-QSAR models, including feature selection, model validation, and performance evaluation, are discussed herewith. Various ML algorithms, such as regression analysis and support vector machines, are showcased in the text for their ability to predict and comprehend the relationships between molecular structures and biological activities. This review serves as a comprehensive guide for researchers, providing an understanding of the synergy between chemoinformatics, QSAR, and ML. Due to embracing these cutting-edge technologies, predictive molecular analysis holds promise for expediting the discovery of novel therapeutic agents in the pharmaceutical sciences.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference106 articles.
1. (2023, May 24). Small Molecule Drug Discovery Market Size, Report by 2032. Available online: https://www.precedenceresearch.com/small-molecule-drug-discovery-market.
2. Chapter 35—Chemoinformatics: What is it and How does it Impact Drug Discovery;Bristol;Annual Reports in Medicinal Chemistry,1998
3. Polanski, J. (2020). Comprehensive Chemometrics, Elsevier. [2nd ed.].
4. Gasteiger, J. (2016). Chemoinformatics: Achievements and Challenges, a Personal View. Molecules, 21.
5. Polanski, J. (2009). Comprehensive Chemometrics, Elsevier.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献